Not recruiting ISRCTN24109245
This study is testing a medication approach for people with Cannabis use and psychosis, Mental and Behavioural Disorders, or Mental and behavioural disorders due to use of cannabinoids. Participants receive a study treatment and complete follow-up visits and assessments.
In Australia Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Other Over 18 Years
Countries Australia
Sponsor University of Wollongong (Australia)
Condition Schizophrenia Completed EUCTR 2021-002572-39
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Germany Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug i A study involving a medication or substance.
Countries Germany
Sponsor Bezirkskliniken Schwaben
Condition Schizophrenia Not recruiting ISRCTN43585723
This study is not recruiting in the United Kingdom. It focuses on schizophrenia.
In United Kingdom Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Other
Countries United Kingdom
Sponsor NHS R&D Regional Programme Register - Department of Health (UK)
Condition Schizophrenia Not recruiting ISRCTN42505388
This study is not recruiting in the United Kingdom. It focuses on Schizophrenia.
In United Kingdom Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Other
Countries United Kingdom
Sponsor Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)
Condition Schizophrenia Terminated NCT03149107
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Mannheim Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Behavioral From 18 Years to 40 Years
Countries Germany
Sponsor University Hospital, Bonn
Condition Schizophrenia Completed NCT02507206
This summary needs review. Please check the official study record and contact the research team for details.
In New York Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries United States
Sponsor Antonia New
Condition Schizophrenia Completed NCT01081418
This summary needs review. Please check the official study record and contact the research team for details.
In Hamburg Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Behavioral From 18 Years to 65 Years
Countries Germany
Sponsor Universitätsklinikum Hamburg-Eppendorf
Condition Schizophrenia Completed NCT03068806
This summary needs review. Please check the official study record and contact the research team for details.
In San Francisco Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Diagnostic Test i A study that looks at how to detect, measure, or better understand a condition. From 18 Years to 75 Years
Countries United States
Sponsor San Francisco Veterans Affairs Medical Center
Condition Schizophrenia Completed NCT01876056
This summary needs review. Please check the official study record and contact the research team for details.
In Lahore Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Behavioral From 18 Years to 65 Years
Countries Pakistan
Sponsor Pakistan Association of Cognitive Therapists
Condition Schizophrenia Active Not Recruiting NCT04105231
This summary needs review. Please check the official study record and contact the research team for details.
In Glostrup Municipality Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 45 Years
Countries Denmark
Sponsor Lone Baandrup
Condition Schizophrenia Completed NCT01701609
This summary needs review. Please check the official study record and contact the research team for details.
In Barcelona Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Behavioral From 12 Years to 18 Years
Countries Spain
Sponsor Hospital Clinic of Barcelona
Condition Schizophrenia Completed NCT00320671
This summary needs review. Please check the official study record and contact the research team for details.
In Glen Oaks Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 15 Years to 40 Years
Countries United States
Sponsor Northwell Health
Condition Schizophrenia